Enablence Technologies Inc. operates in the Ophthalmic goods sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Enablence Technologies Inc. with three other
miscellaneous wholesalers in North America:
Ekso Bionics Holdings Inc
of UNITED STATES
sales of $8.88 million
of which 91%
RedHawk Holdings Corp
(1.52 million Canadian Dollars [US$1.23 million]
based in UNITED STATES
Sales were up sharply during the third
quarter of 2021 versus the previous year's third quarter.
During the third
quarter of 2021, sales at Enablence Technologies Inc. totalled
an increase of 200.0%
from the C$295,295.00 in sales at the company during the third quarter of 2020.
During the first three quarters of 2021, sales totalled C$2.49 million, which is
than through the first three
quarters of 2020.
Enablence Technologies Inc. reported sales of C$1.48 million (US$1.19 million)
June of 2020.
decrease of 21.5%
versus 2019, when the company's sales were C$1.88 million.
Contributing to the drop in overall sales was the 26.4% decline
in Products, from C$1.33 million to C$975,815.75 .
There were also decreases in sales in
Nre (down 9.8% to C$502,001.50 )